期刊文献+

胃肠道恶性淋巴瘤的临床诊治分析

Clinical analysis on clinical diagnosis and treatment of primary gastrointestinal malignant lymphoma
下载PDF
导出
摘要 目的探讨原发性胃肠道恶性淋巴瘤的临床特点、诊断及治疗。方法回顾性分析28例原发性胃肠道恶性淋巴瘤的临床资料。结果28例原发性胃肠道恶性淋巴瘤患者主要表现为腹胀、消瘦,均为非霍奇金淋巴瘤,内镜活检确诊率85.7%,接受手术及化疗等治疗的患者病情均有不同程度好转。结论原发性胃肠道恶性淋巴瘤的临床表现缺乏特异性,误诊率高,患者主要为非霍奇金淋巴瘤,手术加放疗治疗本病疗效较好。 Objective To study the clinical characteristics,diagnosis and treatment of primary gastrointestinal malignant lymphoma (PGML). Method Retrospective analysis on the clinical materials of PGML was performed. Results Twenty-eight patients with PGML manifestated chiefly abdominal distension and bloody stool. All PGML were non Hodgkin's lymphoma. 85.7% patients were diagnosed by endoscopic biopsy and pathology. The patients treated with operation and chemotherapy got well to some extents. Conclusions PGML lacks specific manifestations, so the misdiagnosis rate is high. PGML are chiefly non Hodgkin's lymphoma. They have good response to combined treatment with operation and chemotherapy.
出处 《中国肿瘤临床与康复》 2007年第2期114-115,共2页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 胃肠道肿瘤 淋巴瘤 诊断 治疗 Gastrointestinal neoplasm Lymphoma Diagnosis Treatment
  • 相关文献

参考文献2

二级参考文献24

  • 1Baens M, Maes B, Steyls A et al. The product of the t(11;18), an API2-MLT fusion, marks nearly haly of gastric MALT type lymphomas without large cell proliferation[J]. Am J Pathol,2000,156(4):1433-1439.
  • 2Ohshima K, Muta H, Kawasaki C et al. Bcl10 expression, rearrangement and mutation in MALT lymphoma:correlation with expression of nuclear factor-kappaB[J]. Int J Oncol, 2001,19(2):283-289.
  • 3Liu H, Ye H,Dogan A et al. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10[J]. Blood,2001,98(4):1182-1187.
  • 4Sánchez-Beato M,Sánchez-Aguikera A,Piris MA. Cell cycle deregulation in B-cell lymphomas[J]. Blood,2003,101(4):1220-1235.
  • 5Lin K, Sherrington PD, Dennis M et al. Relationship between p53 dysfunction,CD38 expression, and IgVH mutation in chronic lymphocytic leukemia[J]. Blood,2002,100(4):1404-1409.
  • 6Shaffer AL, Yu X, He Y et al. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control[J]. Immunity,2000,13(2):199-212.
  • 7Rosenwald A, Wright G, Chan WC et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma[J]. N Engl J Med,2002,346(25):1937-1947.
  • 8Lossos IS, Jones CD, Warnke R et al. Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma[J]. Blood,2001,98(4):945-951.
  • 9Boxer LM, Dang CV. Translocations involving c-myc and c-myc function[J]. Oncogene,2001,20(40):5595-5610.
  • 10Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited[J]. Cancer Res,2000,60(14):3689-3695.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部